The Evolution of Cardiac Biomarker Testing in Cardiology (James Januzzi, MD)
The Evolution of Cardiac Biomarker Testing in Cardiology (James Januzzi, MD)
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

The Evolution of Cardiac Biomarker Testing in Cardiology (James Januzzi, MD)

The Evolution of Cardiac Biomarker Testing in Cardiology (James Januzzi, MD)

|
ST2 in heart disease

ST2 in heart disease

|
The Role of ST2 in Managing Patients with Heart Failure By James Januzzi, MD

The Role of ST2 in Managing Patients with Heart Failure By James Januzzi, MD

|
ACC.12 | Biomarker Guided Heart Failure Management

ACC.12 | Biomarker Guided Heart Failure Management

|
Biomarkers in Heart Failure: How to Guide Clinicians

Biomarkers in Heart Failure: How to Guide Clinicians

|
High Sensitivity Troponin in the ICU

High Sensitivity Troponin in the ICU

|
Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials

Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials

|
Two Things Troponin

Two Things Troponin

|
ST2 Heart Failure Biomarker - Dr. James Snider (Critical Diagnostics)

ST2 Heart Failure Biomarker - Dr. James Snider (Critical Diagnostics)

|
ACC.11 | Troponin in Patients with Heart Failure

ACC.11 | Troponin in Patients with Heart Failure

|
Dr. Januzzi on High Sensitivity Troponin Usage in the United States

Dr. Januzzi on High Sensitivity Troponin Usage in the United States

|
ACC.11 | Troponin in Patients with Heart Failure

ACC.11 | Troponin in Patients with Heart Failure

|
Novel Biomarkers for Risk Stratification

Novel Biomarkers for Risk Stratification

|
2016 11 16 WFLHCA Case # 38 - BNP

2016 11 16 WFLHCA Case # 38 - BNP

|
Testing for Soluble ST2: Opening New Perspectives for Cardiovascular Diseases

Testing for Soluble ST2: Opening New Perspectives for Cardiovascular Diseases

|
ACC.11 | Troponin in Patients with Heart Failure

ACC.11 | Troponin in Patients with Heart Failure

|
Implementation of High-Sensitivity Troponin Cardiac Troponin T: The Time is Now | Yader Sandoval, MD

Implementation of High-Sensitivity Troponin Cardiac Troponin T: The Time is Now | Yader Sandoval, MD

|
Lecture series lecture -5 Cardiac Biomarkers

Lecture series lecture -5 Cardiac Biomarkers

|
Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology

Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology

|
CardioAssiut 2020 - Session 5

CardioAssiut 2020 - Session 5

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa